248 related articles for article (PubMed ID: 25377069)
1. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
2. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles.
Dan M; Scott DF; Hardy PA; Wydra RJ; Hilt JZ; Yokel RA; Bae Y
Pharm Res; 2013 Feb; 30(2):552-61. PubMed ID: 23080062
[TBL] [Abstract][Full Text] [Related]
3. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.
Sun Z; Worden M; Wroczynskyj Y; Yathindranath V; van Lierop J; Hegmann T; Miller DW
Int J Nanomedicine; 2014; 9():3013-26. PubMed ID: 25018630
[TBL] [Abstract][Full Text] [Related]
4. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.
Dan M; Cochran DB; Yokel RA; Dziubla TD
PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373
[TBL] [Abstract][Full Text] [Related]
5.
Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanoparticle biodistribution following intratumoral administration.
Giustini AJ; Ivkov R; Hoopes PJ
Nanotechnology; 2011 Aug; 22(34):345101. PubMed ID: 21795772
[TBL] [Abstract][Full Text] [Related]
8. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581
[TBL] [Abstract][Full Text] [Related]
9. Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model.
Ivask A; Pilkington EH; Blin T; Käkinen A; Vija H; Visnapuu M; Quinn JF; Whittaker MR; Qiao R; Davis TP; Ke PC; Voelcker NH
Biomater Sci; 2018 Jan; 6(2):314-323. PubMed ID: 29239410
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
[TBL] [Abstract][Full Text] [Related]
11. Highly Optimized Iron Oxide Embedded Poly(Lactic Acid) Nanocomposites for Effective Magnetic Hyperthermia and Biosecurity.
Ryu C; Lee H; Kim H; Hwang S; Hadadian Y; Mohanty A; Park IK; Cho B; Yoon J; Lee JY
Int J Nanomedicine; 2022; 17():31-44. PubMed ID: 35023918
[TBL] [Abstract][Full Text] [Related]
12. Dynamical Magnetic Response of Iron Oxide Nanoparticles Inside Live Cells.
Cabrera D; Coene A; Leliaert J; Artés-Ibáñez EJ; Dupré L; Telling ND; Teran FJ
ACS Nano; 2018 Mar; 12(3):2741-2752. PubMed ID: 29508990
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Iron Oxide Nanoparticle and Waterbath Hyperthermia Cytotoxicity.
Ogden J; Tate J; Strawbridge R; Ivkov R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810K. PubMed ID: 25301987
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the Preparation of Magnetic Liposomes for the Combined Use of Magnetic Hyperthermia and Photothermia in Dual Magneto-Photothermal Cancer Therapy.
T S A; Lu YJ; Chen JP
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707876
[TBL] [Abstract][Full Text] [Related]
15. An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release.
Sasikala ARK; Unnithan AR; Yun YH; Park CH; Kim CS
Acta Biomater; 2016 Feb; 31():122-133. PubMed ID: 26687978
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models.
Sun Z; Yathindranath V; Worden M; Thliveris JA; Chu S; Parkinson FE; Hegmann T; Miller DW
Int J Nanomedicine; 2013; 8():961-70. PubMed ID: 23494517
[TBL] [Abstract][Full Text] [Related]
17. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier.
Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527
[TBL] [Abstract][Full Text] [Related]
18. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
Hoopes P; Tate J; Ogden J; Strawbridge R; Fiering S; Petryk A; Cassim S; Giustini A; Demidenko E; Ivkov R; Barry S; Chinn P; Foreman A
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810P. PubMed ID: 25346583
[TBL] [Abstract][Full Text] [Related]
19. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter.
Barbaro D; Di Bari L; Gandin V; Evangelisti C; Vitulli G; Schiavi E; Marzano C; Ferretti AM; Salvadori P
PLoS One; 2015; 10(4):e0123159. PubMed ID: 25874906
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA).
Sun Z; Worden M; Thliveris JA; Hombach-Klonisch S; Klonisch T; van Lierop J; Hegmann T; Miller DW
Nanomedicine; 2016 Oct; 12(7):1775-1784. PubMed ID: 27125435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
